People News: Roche NimbleGen and ISI

Share this article:
Roche NimbleGen named Frank Pitzer CEO. Dr. Pitzer was previously head of divisional quality and regulatory affairs at Roche Diagnostics, reporting directly to the CEO, and was also a member of the Diagnostics executive committee.

ISI, a life sciences software company, named Lisa Jenkins, PhD director of regulatory strategy, responsible for advising clients on clinical development and global strategic regulatory affairs. Jenkins was previously associate director/regulatory group leader at Kendle International, and before that she was the principal statistician and senior manager of regulatory affairs at Wyeth.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.